Influence of SARS-CoV-2 variants and corticosteroid use on the effectiveness of baricitinib therapy in critical COVID-19.

Saved in:
Bibliographic Details
Title: Influence of SARS-CoV-2 variants and corticosteroid use on the effectiveness of baricitinib therapy in critical COVID-19.
Authors: You SH; Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Chung-Ang University, Seoul, Republic of Korea., Baek MS; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Kim TW; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea., Jung SY; Department of Global Innovative Drugs, The Graduate School of Chung-Ang University, Chung-Ang University, Seoul, Republic of Korea. jsyoung@cau.ac.kr.; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea. jsyoung@cau.ac.kr., Kim WY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea. wykim81@cau.ac.kr.
Source: Critical care (London, England) [Crit Care] 2025 Mar 22; Vol. 29 (1), pp. 131. Date of Electronic Publication: 2025 Mar 22.
Publication Type: Letter; Comment
Journal Info: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 9801902 Publication Model: Electronic Cited Medium: Internet ISSN: 1466-609X (Electronic) Linking ISSN: 13648535 NLM ISO Abbreviation: Crit Care Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1466-609X
DOI:10.1186/s13054-025-05367-x